Search Results - "HAIT, Howard"

Progesterone replacement with vaginal gel versus i.m. injection: cycle and pregnancy outcomes in IVF patients receiving vitrified blastocysts by Shapiro, Daniel B, Pappadakis, Jennifer A, Ellsworth, Nancy M, Hait, Howard I, Nagy, Zsolt Peter

“…Does the type of luteal support affect pregnancy outcomes in recipients of vitrified blastocysts? Luteal support with vaginal progesterone gel or i.m…”
Get full text

A Randomized, Evaluator-Blind, Phase 2 Study Comparing the Safety and Efficacy of Omadacycline to Those of Linezolid for Treatment of Complicated Skin and Skin Structure Infections by NOEL, Gary J, DRAPER, Michael P, HAIT, Howard, KEN TANAKA, S, ARBEIT, Robert D

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive by Westhoff, Carolyn L, Hait, Howard I, Reape, Kathleen Z

“…Abstract Background This study evaluated the impact of weight on efficacy during use of an extended oral contraceptive (OC). Study Design Data were from a…”
Get full text

Synthetic Conjugated Estrogens-B and Postmenopausal Nocturnal Vasomotor Symptoms: A Randomized Controlled Trial by Liu, James H, Reape, Kathleen Z, Hait, Howard I

“…OBJECTIVE:To evaluate two doses of oral synthetic conjugated estrogens-B tablets compared with placebo on the frequency of awakenings resulting from nocturnal…”
Get full text

Randomized, multicenter, double-blind, placebo-controlled trial to evaluate the efficacy and safety of synthetic conjugated estrogens B for the treatment of vulvovaginal atrophy in healthy postmenopausal women by Simon, James A., M.D, Reape, Kathleen Z., M.D, Wininger, Steve, M.D, Hait, Howard, M.S

“…Objective To evaluate the safety and efficacy of synthetic conjugated estrogens B (SCE-B; 0.3 mg/d) for 12 weeks in the treatment of vulvovaginal atrophy in…”
Get full text

A Phase I/IIA Trial of Continuous Five-Day Infusion of Squalamine Lactate (MSI-1256F) Plus Carboplatin and Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer by HERBST, Roy S, HAMMOND, Lisa A, SOLOMON, Stephen, SCHILLER, Joan H, CARBONE, David P, TRAN, Hai T, HOLROYD, Kenneth J, DESAI, Avinash, WILLIAMS, Jon I, NEBIYOU BEKELE, B, HAIT, Howard, ALLGOOD, Victoria

“…Purpose: Squalamine is an antitumor agent that has been shown to have antiangiogenic activity in animal models. This Phase I/IIA study was designed to assess…”
Get full text

A Phase I and Pharmacokinetic Study of Squalamine, a Novel Antiangiogenic Agent, in Patients with Advanced Cancers by BHARGAVA, Pankaj, MARSHALL, John L, DAHUT, William, RIZVI, Naiyer, TROCKY, Nina, WILLIAMS, Jon I, HAIT, Howard, SONG, Sharon, HOLROYD, Kenneth J, HAWKINS, Michael J

“…Purpose: A Phase I study of squalamine, a novel antiangiogenic agent originally isolated from the dogfish shark Squalus acanthias , was conducted in patients…”
Get full text

In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers by Ge, Yigong, MacDonald, Dorothy, Henry, Marietta M, Hait, Howard I, Nelson, Kimberly A, Lipsky, Benjamin A, Zasloff, Michael A, Holroyd, Kenneth J

“…During two clinical trials involving the treatment of 835 outpatients with infected diabetic foot ulcers, 2515 bacterial isolates, including 2337 aerobes and…”
Get full text

Pharmacokinetics of nalbuphine hydrochloride extended release tablets in hemodialysis patients with exploratory effect on pruritus by Hawi, Amale, Alcorn, Jr, Harry, Berg, Jolene, Hines, Carey, Hait, Howard, Sciascia, Thomas

“…Uremic pruritus is a common and deleterious condition among hemodialysis (HD) patients. Central gating of μ/κ opiate circuitry plays an important role in…”
Get full text

Measuring symptom relief in studies of vaginal and vulvar atrophy: the most bothersome symptom approach by Ettinger, Bruce, Hait, Howard, Reape, Kathleen Z, Shu, Haibin

“…To assess the importance and usefulness of self-reported symptom data, especially the most bothersome symptom, in the evaluation of treatment for vulvovaginal…”
Get full text

A phase 3, randomized, double-blind, placebo-controlled study of the safety and efficacy of the live, oral adenovirus type 4 and type 7 vaccine, in U.S. military recruits by Kuschner, Robert A, Russell, Kevin L, Abuja, Mary, Bauer, Kristen M, Faix, Dennis J, Hait, Howard, Henrick, Jennifer, Jacobs, Michael, Liss, Alan, Lynch, Julia A, Liu, Qi, Lyons, Arthur G, Malik, Mohammad, Moon, James E, Stubbs, Jeremiah, Sun, Wellington, Tang, Doug, Towle, Andrew C, Walsh, Douglas S, Wilkerson, Deborah

“…Highlights • An efficacy trial of a new adenovirus vaccine was performed in military recruits. • 4040 volunteers were randomized in a 3:1 ratio of vaccine to…”
Get full text

A Phase 1/2 Trial of Investigational Spk-8011 in Hemophilia a Demonstrates Durable Expression and Prevention of Bleeds by High, Katherine A., George, Lindsey A., Eyster, M. Elaine, Sullivan, Spencer K., Ragni, Margaret V., Croteau, Stacy E., Samelson-Jones, Ben J., Evans, Matthew, Joseney-Antoine, Marcelyne, Macdougall, Amy, Kadosh, Judith, Runoski, Alexa R., Campbell-Baird, Cynthia, Douglas, Kayla, Tompkins, Summer, Hait, Howard, Couto, Linda B., Bassiri, Ashlyn Eaton, Valentino, Leonard A., Carr, Marcus E., Hui, Daniel J, Wachtel, Katie, Takefman, Daniel, Mingozzi, Federico, Anguela, Xavier M., Reape, Kathleen B

“…▪ Gene transfer for hemophilia A offers the potential for a one-time disease altering treatment, eliminating the risk of bleeds while freeing patients from the…”
Get full text

Patients' choice of treatment in stage D prostate cancer by Cassileth, B R, Soloway, M S, Vogelzang, N J, Schellhammer, P S, Seidmon, E J, Hait, H I, Kennealey, G T

“…Given the current preference of many patients for an active role in decision-making regarding their care, the feasibility of patients making their own…”
Get more information

Twice-weekly synthetic conjugated estrogens vaginal cream for the treatment of vaginal atrophy by Freedman, Murray, Kaunitz, Andrew M., Reape, Kathleen Z., Hait, Howard, Shu, Haibin

“…OBJECTIVE:The aim of this study was to evaluate low-dose synthetic conjugated estrogens A (SCE-A) cream administered twice weekly for the treatment of moderate…”
Get full text

Adding low-dose estrogen to the hormone-free interval: impact on bleeding patterns in users of a 91-day extended regimen oral contraceptive by Kaunitz, Andrew M, Portman, David J, Hait, Howard, Reape, Kathleen Z

“…Abstract Background A cross-study analysis of contraceptive clinical trials for two different 91-day oral contraceptive (OC) regimens was performed to examine…”
Get full text

Erratum to “a multicenter, randomized study of an extended cycle oral contraceptive” [contraception 68 (2003) 89–96] by Anderson, F.D., Hait, Howard

Get full text

Evaluation of the long-term safety of a 91-day extended regimen oral contraceptive with low-dose estrogen in place of placebo by Davis, Matthew, Reape, Kathleen Z, Hait, Howard

Get full text

Bleeding patterns in users of a 91-day extended regimen oral contraceptive with low-dose estrogen in place of placebo compared to a conventional 28-day regimen by Feldman, Robert, Reape, Kathleen Z, Hait, Howard

Get full text

Efficacy and safety of a 28-day oral contraceptive with 7 days of low-dose estrogen in place of placebo by Poindexter, Alfred, Reape, Kathleen Z, Hait, Howard

“…Abstract Background The study was conducted to evaluate the efficacy and safety for the prevention of pregnancy of a 28-day oral contraceptive (OC) containing…”
Get full text

A look at the long-term safety of an extended-regimen OC by Davis, Matthew G, Reape, Kathleen Z, Hait, Howard

“…Oral contraceptives (OCs) are the most widely used method of reversible contraception. Recent alterations of the standard 28-day regimen have included…”
Get full text